Financhill
Buy
82

HIMS Quote, Financials, Valuation and Earnings

Last price:
$54.83
Seasonality move :
-1.89%
Day range:
$52.88 - $55.37
52-week range:
$13.47 - $72.98
Dividend yield:
0%
P/E ratio:
79.46x
P/S ratio:
7.41x
P/B ratio:
22.34x
Volume:
23.6M
Avg. volume:
47.2M
1-year change:
246.37%
Market cap:
$12.3B
Revenue:
$1.5B
EPS (TTM):
$0.69

Analysts' Opinion

  • Consensus Rating
    Hims & Hers Health has received a consensus rating of Hold. The company's average rating is a Hold based on 4 Buy ratings, 7 Hold ratings, and 1 Sell rating.
  • Price Target Downside
    According to analysts' consensus price target of $46.95, Hims & Hers Health has an estimated downside of -14.37% from its current price of $54.83.
  • Price Target Upside
    According to analysts, the highest upside price target is $85.00 representing 55.03% upside increase from its current price of $54.83.

Fair Value

  • According to the consensus of 12 analysts, Hims & Hers Health has -14.37% downside to fair value with a price target of $46.95 per share.

HIMS vs. S&P 500

  • Over the past 5 trading days, Hims & Hers Health has underperformed the S&P 500 by -12.92% suggesting its relative strength compared to the major market average is weak at this time.

Share Buyback

  • Hims & Hers Health does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Hims & Hers Health has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Hims & Hers Health reported revenues of $586M.

Earnings Growth

  • Hims & Hers Health has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Hims & Hers Health reported earnings per share of $0.20.
Enterprise value:
12B
EV / Invested capital:
21.76x
Price / LTM sales:
7.41x
EV / EBIT:
108.74x
EV / Revenue:
6.70x
PEG ratio (5yr expected):
--
EV / Free cash flow:
50.53x
Price / Operating cash flow:
55.89x
Enterprise value / EBITDA:
90.35x
Gross Profit (TTM):
$1.4B
Return On Assets:
26.26%
Net Income Margin (TTM):
9.21%
Return On Equity:
37.84%
Return On Invested Capital:
37.84%
Operating Margin:
9.88%
Trailing 12 Months Fiscal Quarters
Period Ending 2023-03-31 2024-03-31 2025-03-31 2024-03-31 2025-03-31
Income Statement
Revenue $616.4M $959.4M $1.8B $278.2M $586M
Gross Profit $487.4M $790.6M $1.4B $229.1M $430.7M
Operating Income -$63M -$8.3M $109.9M $9.9M $57.9M
EBITDA -$55.2M $2.1M $132.3M $12.9M $66.2M
Diluted EPS -$0.29 -$0.01 $0.69 $0.05 $0.20
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Balance Sheet
Current Assets $340.2M $231.9M $225.5M $261.7M $447M
Total Assets $345.9M $382M $376.3M $448.1M $891.7M
Current Liabilities $19.7M $48.5M $56.3M $93.3M $280.4M
Total Liabilities $53.4M $54.3M $63.6M $103.6M $342.5M
Total Equity $292.5M $327.7M $312.7M $344.5M $549.3M
Total Debt -- -- -- -- --
Trailing 12 Months Fiscal Quarters
Period Ending 2023-03-31 2024-03-31 2025-03-31 2024-03-31 2025-03-31
Cash Flow Statement
Cash Flow Operations $2.4M $89.8M $334.3M $25.8M $109.1M
Cash From Investing $12.1M $5M -$64.9M $13M -$32.8M
Cash From Financing -$14M -$38.4M -$100.6M -$30.3M -$23M
Free Cash Flow -$6.1M $51.9M $236.5M $11.9M $50.1M
HIMS
Sector
Market Cap
$12.3B
$34.8M
Price % of 52-Week High
75.13%
44.2%
Dividend Yield
0%
0%
Shareholder Yield
0.83%
-0.6%
1-Year Price Total Return
246.37%
-41.1%
Beta (5-Year)
1.846
0.659
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years

Technicals

8-day SMA
Sell
Level $59.28
200-day SMA
Buy
Level $29.39
Bollinger Bands (100)
Buy
Level 25.84 - 49.38
Chaikin Money Flow
Buy
Level 378.4M
20-day SMA
Buy
Level $50.71
Relative Strength Index (RSI14)
Buy
Level 58.48
ADX Line
Buy
Level 34.44
Williams %R
Neutral
Level -39.9566
50-day SMA
Buy
Level $38.26
MACD (12, 26)
Buy
Level 6.49
25-day Aroon Oscillator
Buy
Level 64
On Balance Volume
Neutral
Level 573.7M

Financial Scores

Buy
Altman Z-Score (Annual)
Level (16.0727)
Buy
CA Score (Annual)
Level (2.0165)
--
Beneish M-Score (Annual)
Level (--)
Buy
Momentum Score
Level (10)
Buy
Ohlson Score
Level (-2.3964)
Buy
Piotroski F Score (Annual)
Level (6)
Buy
Quality Ratio Score
Level (7)
Buy
Fundamental Score
Level (5)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Hims & Hers Health Inc is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions related to mental health, sexual health, dermatology, haircare and more.

Stock Forecast FAQ

In the current month, HIMS has received 4 Buy ratings 7 Hold ratings, and 1 Sell ratings. The HIMS average analyst price target in the past 3 months is $46.95.

  • Where Will Hims & Hers Health Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Hims & Hers Health share price will drop to $46.95 per share over the next 12 months.

  • What Do Analysts Say About Hims & Hers Health?

    Analysts are divided on their view about Hims & Hers Health share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Hims & Hers Health is a Sell and believe this share price will rise from its current level to $25.00.

  • What Is Hims & Hers Health's Price Target?

    The price target for Hims & Hers Health over the next 1-year time period is forecast to be $46.95 according to 12 Wall Street analysts, 4 of them rate the stock a Buy, 1 rates the stock a Sell, and 7 analysts rate the stock a Hold.

  • Is HIMS A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Hims & Hers Health is a Hold. 7 of 12 analysts rate the stock a Hold at this time.

  • How Can I Buy Shares Of HIMS?

    You can purchase shares of Hims & Hers Health via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Hims & Hers Health shares.

  • What Is The Hims & Hers Health Share Price Today?

    Hims & Hers Health was last trading at $54.83 per share. This represents the most recent stock quote for Hims & Hers Health. Yesterday, Hims & Hers Health closed at $54.83 per share.

  • How To Buy Hims & Hers Health Stock Online?

    In order to purchase Hims & Hers Health stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Rambus (RMBS) Stock Forecast, Can the Rally Continue in 2025?
Rambus (RMBS) Stock Forecast, Can the Rally Continue in 2025?

Rambus has flown under the radar, but the numbers tell…

Celsius Stock Forecast: Will Earnings Spark Another Surge?
Celsius Stock Forecast: Will Earnings Spark Another Surge?

Energy drink seller Celsius Holdings, Inc. (NASDAQ:CELH) has reported somewhat…

Will DigitalOcean Stock Bounce Back?
Will DigitalOcean Stock Bounce Back?

DigitalOcean (NYSE:DOCN) has run into the proverbial brick wall with…

Stock Ideas

Buy
65
Is MSFT Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 38x

Buy
65
Is NVDA Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 45x

Sell
33
Is AAPL Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 32x

Alerts

Buy
60
MRUS alert for May 24

Merus NV [MRUS] is up 32.55% over the past day.

Buy
57
RGC alert for May 24

Regencell Bioscience Holdings [RGC] is up 28.43% over the past day.

Buy
90
OKLO alert for May 24

Oklo [OKLO] is up 23.11% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock